The answers to these sorts of questions will undoubtedly provide unique insights into the roles of IL‐22 in atherosclerosis and make IL‐22 an attractive therapeutic target for therapy aiming at the reduction of atherogenesis. The gene discussed is IL22; the disease is atherosclerosis.